Fig. 3
From: Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas
Kaplan Meier curves illustrating associations between temporal CDKN2A deletion status and time to progression (a, c, e) or time to next surgery (b, d, f) among patients who had CDKN2A deletion testing performed on paired tumor specimens. Shown are comparisons between patients whose tumors acquired CDKN2A deletions versus patients whose tumors did not acquire this genetic alteration (a, b), versus patients whose tumors had conserved CDKN2A deletions from diagnosis (c, d), and versus patients whose tumors lost CDKN2A deletions (e, f)